1. Home
  2. BNTC vs ZH Comparison

BNTC vs ZH Comparison

Compare BNTC & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • ZH
  • Stock Information
  • Founded
  • BNTC 1995
  • ZH 2011
  • Country
  • BNTC United States
  • ZH China
  • Employees
  • BNTC 16
  • ZH N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • ZH Business Services
  • Sector
  • BNTC Health Care
  • ZH Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • ZH Nasdaq
  • Market Cap
  • BNTC 322.6M
  • ZH 309.5M
  • IPO Year
  • BNTC N/A
  • ZH 2021
  • Fundamental
  • Price
  • BNTC $13.75
  • ZH $3.53
  • Analyst Decision
  • BNTC Strong Buy
  • ZH Strong Buy
  • Analyst Count
  • BNTC 7
  • ZH 1
  • Target Price
  • BNTC $24.71
  • ZH $4.70
  • AVG Volume (30 Days)
  • BNTC 64.1K
  • ZH 593.8K
  • Earning Date
  • BNTC 05-12-2025
  • ZH 06-11-2025
  • Dividend Yield
  • BNTC N/A
  • ZH N/A
  • EPS Growth
  • BNTC N/A
  • ZH N/A
  • EPS
  • BNTC N/A
  • ZH N/A
  • Revenue
  • BNTC N/A
  • ZH $493,061,473.00
  • Revenue This Year
  • BNTC N/A
  • ZH $9.28
  • Revenue Next Year
  • BNTC N/A
  • ZH $73.00
  • P/E Ratio
  • BNTC N/A
  • ZH N/A
  • Revenue Growth
  • BNTC N/A
  • ZH N/A
  • 52 Week Low
  • BNTC $5.08
  • ZH $2.55
  • 52 Week High
  • BNTC $16.90
  • ZH $6.32
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 55.16
  • ZH 35.26
  • Support Level
  • BNTC $13.26
  • ZH $3.25
  • Resistance Level
  • BNTC $14.22
  • ZH $3.89
  • Average True Range (ATR)
  • BNTC 1.37
  • ZH 0.24
  • MACD
  • BNTC 0.08
  • ZH -0.03
  • Stochastic Oscillator
  • BNTC 87.27
  • ZH 23.14

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About ZH Zhihu Inc. (every two of each representing one ordinary share)

Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.

Share on Social Networks: